Observational studyMultiple sclerosis and related disorders2022

Humoral and cellular immune responses to SARS CoV-2 vaccination in People with Multiple Sclerosis and NMOSD patients receiving immunomodulatory treatments.

H Bock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.